Personalized chemo tested for tough breast cancers
Disease control
Terminated
This study tested whether a chemotherapy drug called ixabepilone could help control advanced breast cancer that had stopped responding to standard treatments. Researchers used a special test (the DRP) to predict which patients' tumors were most likely to respond. The trial was sm…
Phase: PHASE2 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC